Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal timing of adjuvant treatment in patients with early breast cancer.
Alkis N, Durnali AG, Arslan UY, Kocer M, Onder FO, Tokluoglu S, Celenkoglu G, Muallaoglu S, Utkan G, Ulas A, Altundag K. Alkis N, et al. Among authors: ulas a. Med Oncol. 2011 Dec;28(4):1255-9. doi: 10.1007/s12032-010-9566-4. Epub 2010 May 15. Med Oncol. 2011. PMID: 20473647
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab.
Tonyali O, Coskun U, Sener N, Inanc M, Akman T, Ulas A, Yazilitas D, Bal O, Kucukoner M, Yildirim Ozdemir N, Demirci U, Gunaydin Y, Yildiz R, Karaca H, Umit Unal O, Gumus M, Benekli M, Buyukberber S. Tonyali O, et al. Among authors: ulas a. Onkologie. 2013;36(10):554-8. doi: 10.1159/000355156. Epub 2013 Sep 16. Onkologie. 2013. PMID: 24107908
The relationship between adjuvant chemotherapy and thiol-disulfide compounds.
Akyol P, Dede DŞ, Bilgin B, Ulaş A, Sendur Mehmet AN, Akıncı MB, Başer S, Erol C, Hızal M, Yalçın B. Akyol P, et al. Among authors: ulas a. J Cancer Res Ther. 2022 Jul-Sep;18(4):1114-1118. doi: 10.4103/jcrt.JCRT_32_20. J Cancer Res Ther. 2022. PMID: 36149169 Free article.
Risk factors for stage IV breast cancer at the time of presentation in Turkey.
Uyeturk U, Tatli AM, Gucuk S, Oksuzoglu B, Ulas A, Avci N, Ozbay MF, Gunduz S, Akinci MB, Salim DK, Sonmez OU, Akdag F, Ergenc H. Uyeturk U, et al. Among authors: ulas a. Asian Pac J Cancer Prev. 2013;14(12):7445-9. doi: 10.7314/apjcp.2013.14.12.7445. Asian Pac J Cancer Prev. 2013. PMID: 24460317 Free article.
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.
Tonyali O, Coskun U, Yuksel S, Inanc M, Bal O, Akman T, Yazilitas D, Ulas A, Kucukoner M, Aksoy A, Demirci U, Uysal M, Tanriverdi O, Gunaydin Y, Sumbul AT, Yildiz R, Karaca H, Oksuzoglu B, Ciltas A, Buyukberber S, Benekli M; Anatolian Society of Medical Oncology (ASMO). Tonyali O, et al. Among authors: ulas a. Breast. 2016 Feb;25:22-6. doi: 10.1016/j.breast.2015.11.006. Epub 2015 Dec 20. Breast. 2016. PMID: 26801412
116 results